Aptose Biosciences Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
APTOF on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
66 Wellington Street West, Suite 5300, Td Bank Tower Box 48, Toronto, Ontario, Canada

Insiders trading volume in the past year

Aptose Biosciences Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Donald R. Wilson Jr. 10%+ Owner $27.9M Aug 3, 2021
William G. Rice Chair, President & CEO, Director $123K +$20K +19.5% Nov 25, 2024
Hanmi Pharmaceutical Co., Ltd. 10%+ Owner $102K Mar 18, 2025
Bernd R. Seizinger Director $53.4K Feb 5, 2024
Mark D. Vincent Director Feb 5, 2024
Jotin Marango Senior VP, CFO, and CBO Jan 18, 2022
Philippe Ledru Former Officer Feb 23, 2024
Denis R. Burger Director Feb 5, 2024
Erich Platzer Director Feb 5, 2024
Carol Ashe Director Feb 5, 2024
Caroline M. Loewy Former Director May 31, 2022
Rafael Bejar Sr VP & Chief Medical Officer Feb 5, 2024
Warren Whitehead Director Feb 5, 2024
Fletcher Payne Sr VP and CFO Feb 5, 2024

Recent Insider Transactions by Companies or Individuals for Aptose Biosciences Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.